Omenn syndrome due to ARTEMIS mutations

Blood

Volumn 105, Issue 11, 2005, Pages 4179-4186

  Ege, Markus ^b   Ma, Yunmei ^b   Manfras, Burkhard ^b   Kalwak, Krzysztof ^b   Lu, Haihui ^b   Lieber, Michael R ^b   Schwarz, Klaus ^a   Pannicke, Ulrich ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; PROTEIN; PROTEIN ARTEMIS; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; GENE MUTATION; GENE SEQUENCE; GENETIC RECOMBINATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; OMENN SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; SKIN FIBROBLAST; T LYMPHOCYTE;

EID: 19344374008     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4861     Document Type: Article

References (42)

1. Omenn GS. Familial reticuloendotheliosis with eosinophilia. N Engl J Med. 1965;273:427-432.
2. Villa A, Sobacchi C, Vezzoni P. Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies. Isr Med Assoc J. 2002;4:218-221.
3. de Saint-Basile G, Le Deist F, de Villartay JP, et al. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest. 1991; 87:1352-1359.
4. Pirovano S, Mazzolari E, Pasic S, Albertini A, Notarangelo LD, Imberti L. Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immunol Lett. 2003;86:93-97.
5. + T lymphocytes in Omenn syndrome. J Clin Immunol. 1997; 17:322-332.
6. Schandene L, Ferster A, Mascart-Lemone F, et al. T helper type 2-like cells and therapeutic effects of interteron-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol. 1993;23:56-60.
7. Chilosi M, Facchetti F, Notarangelo LD, et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol. 1996;26:329-334.
8. Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001;160:718-725.
9. Kumaki S, Villa A, Asada H, et al. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency. Blood. 2001;98:1464-1468.
10. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998;93:885-896.
11. Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81-88.
12. Santagata S, Villa A, Sobacchi C, Cortes P, Vezzoni P. The genetic and biochemical basis of Omenn syndrome. Immunol Rev. 2000;178:64-74.
13. Wada T, Takei K, Kudo M, et al. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol. 2000;119:148-155.
14. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol. 2000;18:495-527.
15. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002;71:101-132.
16. Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 1990;248:1517-1523.
17. Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035-1048.
18. Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin opening and overhang processing by an Artemis/ DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell. 2002;108:781-794.
19. Le Deist F, Poinsignon C, Moshous D, Fischer A, de Villartay JP. Artemis sheds new light on V(D)J recombination. Immunol Rev. 2004;200:142-155.
20. Noordzij JG, Verkaik NS, van der Burg M, et al. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Blood. 2003;101:1446-1452.
21. Moshous D, Callebaut I, de Chasseval R, et al. Artemis, a novel DNA double-strand break repair/ V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2001; 105:177-186.
22. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol. 2002;118:74-89.
23. Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood. 2001;98:1847-1851.
24. Muller SM, Kohn T, Schulz AS, Debatin KM, Friedrich W. Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation. Blood. 2000;96:4344-4349.
25. Kalwak K, Ussowicz M, Turkiewicz D, et al. Clinical use of non-radioactive flow-cytometric natural killer cell cytotoxicity assay in children undergoing bone marrow or peripheral blood progenitor cell transplantation. Centr Eur J Immunol. 2000;25:52-56.
26. Kalwak K, Ussowicz M, Gorczynska E, et al. Immunologic effects of intermediate-dose IL-2 i.v. after autologous hematopoietic cell transplantation in pediatric solid tumors. J Interferon Cytokine Res. 2003;23:173-181.
27. Knobloch C, Goldmann SF, Friedrich W. Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Immunol. 1991;146:4157-4164.
28. Manfras BJ, Rudert WA, Trucco M, Boehm BO. Analysis of the alpha/beta T-cell receptor repertoire by competitive and quantitative family-specific PCR with exogenous standards and high resolution fluorescence based CDR3 size imaging. J Immunol Methods. 1997;210:235-249.
29. + repertoire during antiviral therapy. Nat Med. 1998;4:215-221.
30. Moss PA, Bell JI. Sequence analysis of the human alpha beta T-cell receptor CDR3 region. Immunogenetics. 1995;42:10-18.
31. Moss PA, Bell JI. Comparative sequence analysis of the human T cell receptor TCRA and TCRB CDR3 regions. Hum Immunol. 1996;48:32-38.
32. Wigler M, Sweet R, Sim GK, et al. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell. 1979;16:777-785.
33. Pannicke U, Ma Y, Hopfner KP, Niewolik D, Lieber MR, Schwarz K. Functional and biochemical dissection of the structure-specific nuclease ARTEMIS. EMBO J. 2004;23:1987-1997.
34. Dati F, Schumann G, Thomas L, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem. 1996;34:517-520.
35. Soldin SJ, Morales A, Albalos F et al. Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. Clin Biochem. 1995;28:603-606.
36. Corneo B, Moshous D, Gungor T, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood. 2001;97:2772-2776.
37. Noordzij JG, de Bruin-Versteeg S, Verkaik NS, et al. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. Blood. 2002;100:2145-2152.
38. Poinsignon C, Moshous D, Callebaut I, de Chasseval R, Villey I, de Villartay JP. The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the catalytic core for V(D)J recombination. J Exp Med. 2004;199:315-321.
39. Mehdi H, Ono E, Gupta KC. Initiation of translation at CUG, GUG, and ACG codons in mammalian cells. Gene. 1990;91:173-178.
40. Umehara F, Tate G, Itoh K, et al. A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet. 2000;67:1302-1305.
41. Jankovic L, Efremov GD, Josifovska O, et al. An initiation codon mutation as a cause of a beta-thalassemia. Hemoglobin. 1990;14:169-176.
42. Gupta A, Hattori Y, Agarwal S. Initiation codon mutation in an Asian Indian family. Am J Hematol. 2002;71:134-136.